Abstract
The field of tissue engineering and gene therapy has an exciting and promising future. During the past few years we have begun a comprehensive effort to investigate the use of myoblasts to improve and expand the treatment of stress urinary incontinence and bladder dysfunction. Moreover, we can expect the application of myoblast-mediated ex vivo gene transfer in the field of urology. In this paper we discuss the compositions of and methods involving the use of myogenic or muscle-derived cells for tissue engineering and cell-mediated gene therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yokoyama, T., Huard, J. & Chancellor, M. Myoblast therapy for stress urinary incontinence and bladder dysfunction. World J Urol 18, 56–61 (2000). https://doi.org/10.1007/s003450050010
Issue Date:
DOI: https://doi.org/10.1007/s003450050010